| View |
|
DRP-11128-04
|
Cetirizine dihydrochloride
|
Retanix
|
10 mg
|
Film-Coated Tablet
|
-
|
Akriti Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 November 2022
|
29 September 2026
|
| View |
|
DRP-11171-01
|
Tranexamic Acid
|
Triqox
|
100 mg/mL
|
Solution for Injection (IV)
|
-
|
Indus Pharma (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
28 November 2022
|
08 February 2027
|
| View |
|
DRP-11402-02
|
Folic Acid
|
Natalgen
|
5 mg
|
Tablet
|
-
|
Acme Formulation Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 November 2022
|
09 March 2027
|
| View |
|
DRP-11462-03
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazopro
|
4 g/ 500 mg x
|
Powder for Injection (I.V.)
|
-
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
28 November 2022
|
15 March 2027
|
| View |
|
DRP-11463-02
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazopro
|
2 g/ 250 mg
|
Powder for Injection ( I.V.)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
28 November 2022
|
15 March 2027
|
| View |
|
DRP-5683-19
|
CEFIXIME
|
NIBEXIME
|
20mg/mL
|
Granules for Suspension (Oral Drops)
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
Renewal
|
19 December 2023
|
20 February 2029
|
| View |
|
DRP-7074-10
|
Meropenem (as trihydrate)
|
Grobinem
|
1 g
|
Powder for Injection (IV)
|
-
|
Daffodills Pharmaceuticals Ltd
|
India
|
CLIDP Conversion
|
26 November 2022
|
06 March 2027
|
| View |
|
DRP-3431-08
|
Azithromycin (as monohydrate)
|
Rexithro LQ
|
200 mg/5 mL
|
Suspension
|
Antibacterial (Macrolide)
|
Akums Drugs & Pharmaceuticals Ltd
|
India
|
Renewal
|
08 April 2024
|
07 December 2029
|
| View |
|
DRP-5930-05
|
Omeprazole Sodium
|
Omepratel
|
40 mg
|
Lyophilized Powder for Injection
|
-
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
Renewal
|
18 October 2023
|
05 December 2028
|
| View |
|
DRP-12319-01
|
Carboplatin
|
Carbo-Health 150
|
10 mg/mL (450mg/45mL)
|
Solution for Injection for IV Infusion
|
Antineoplastic
|
Admac Lifesciences
|
India
|
Renewal
|
16 April 2023
|
29 July 2028
|
| View |
|
DRP-7320-01
|
Azithromycin (as dihydrate)
|
Zalimed
|
500 mg
|
Tablet
|
Antibacterial (Macrolide)
|
Saga Lifesciences Limited
|
India
|
Renewal
|
20 October 2024
|
08 October 2029
|
| View |
|
DRP-8070-05
|
Cefixime (as trihydrate)
|
Ximebac
|
200 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
24 November 2022
|
13 April 2025
|
| View |
|
DRP-2258-01
|
Metoclopramide Hydrochloride
|
JIAASIL
|
10mg
|
Tablet
|
-
|
New Myrex Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
23 November 2022
|
15 June 2025
|
| View |
|
DRP-4501-03
|
Levocetirizine Dihydrochloride
|
Amkohist
|
5 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
23 November 2022
|
28 June 2028
|
| View |
|
DRP-12551-02
|
Sodium Bicarbonate
|
Aenabi
|
84 mg/mL (8.4% w/v)
|
Solution for Injection (I.V.)
|
-
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
23 November 2022
|
09 September 2027
|
| View |
DRP-5260-03_PI_01.pdf
|
DRP-5260-03
|
Dexamethasone
|
Dexotab
|
500 mcg
|
Tablet
|
Corticosteroid
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
22 November 2022
|
19 April 2027
|
| View |
|
DRP-5881-06
|
Esomeprazole (as sodium)
|
Acerblock
|
40 mg
|
Lyophilized Powder for IV Injection
|
Proton Pump Inhibitor
|
Gufic Biosciences Limited
|
India
|
CLIDP Conversion
|
22 November 2022
|
09 December 2027
|
| View |
|
DRP-8059-02
|
Atorvastatin (as Calcium)
|
None
|
20 mg
|
Film-Coated Tablet
|
-
|
Akriti Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
22 November 2022
|
27 March 2027
|
| View |
|
DRP-9387-02
|
Diosmin + Hesperidin
|
Hesdiomax
|
450mg/50mg
|
Film-Coated Tablet
|
Vasoprotective
|
Alwin DMD Pharmaceuticals
|
India
|
CLIDP Conversion
|
22 November 2022
|
17 December 2025
|
| View |
|
DRP-9390-08
|
Telmisartan
|
Telcor 40
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics Private Limited
|
India
|
CLIDP Conversion
|
22 November 2022
|
02 March 2026
|